SCHEMBL7070900

SCHEMBL7070900

C[C@H](N[C@@H](CO)[C@H](O)CO)c1cnc(C[C@H](O)[C@H](O)CO)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7074549 1.00 — —
SCHEMBL7070308 1.00 — —
SCHEMBL7072631 1.00 — —
SCHEMBL8060304 0.85 — —
SCHEMBL8060413 0.85 — —
SCHEMBL7070573 0.82 — —
SCHEMBL7070795 0.82 — —
SCHEMBL7070747 0.82 — —
SCHEMBL7071005 0.82 — —
SCHEMBL7072329 0.75 PNP (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001942-B1 POLYHYDROXYBUTYLPYRAZINES, THEIR PREPARATION AND MEDICINES CONTAINING THEM AVENTIS PHARMA SA (FR) 2003-06-25 — — EP claimed
US-6288066-B1 ANTIDIABETIC AGENTS; OXIDATION, HYDROLYSIS AVENTIS PHARMA S.A. (FR) 2001-09-11 — — US claimed
EP-1001942-B1 POLYHYDROXYBUTYLPYRAZINES, THEIR PREPARATION AND MEDICINES CONTAINING THEM AVENTIS PHARMA SA (FR) 2003-06-25 — — EP disclosed
US-6288066-B1 ANTIDIABETIC AGENTS; OXIDATION, HYDROLYSIS AVENTIS PHARMA S.A. (FR) 2001-09-11 — — US disclosed
EP-1001942-A1 POLYHYDROXYBUTYLPYRAZINES, THEIR PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 — — EP disclosed
WO-1999003841-A1 POLYHYDROXYBUTYLPYRAZINES, THEIR PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 — — WO disclosed
Send feedback